top
Gilgamesh Pharmaceuticals Completes Phase 1 SAD Clinical Trial of GM-2505
![Jonathan-Javitt-NRx Jonathan Javitt](https://psychedelicmedicalnews.com/wp-content/uploads/2023/12/Jonathan-Javitt-NRx-500x300.jpg)
NRx Pharmaceuticals Founder Jonathan Javitt Discusses Company’s Mission, Pipeline in Nasdaq Interview
![Centre for Mental Health Centre for Mental Health](https://psychedelicmedicalnews.com/wp-content/uploads/2023/11/Centre-for-Mental-Health-1024x512-500x300.jpg)
Compass Launches Phase 3 Psilocybin Study in UK
![Ketamine. Dissociative ketamine. Chemical formula, molecular structure. Ilustration background for your desigen. Disoviative drugs. Ketamin banner. Ketamine. Dissociative ketamine. Chemical formula, molecular structure. Ilustration background for your desigen. Disoviative drugs. Ketamin banner.](https://psychedelicmedicalnews.com/wp-content/uploads/2023/11/Depositphotos_616738402_L-1024x662-500x300.jpg)
NRx Pharmaceuticals Plans to Spin Off Ketamine-Focused Company
![Veterans Access Veterans Access](https://psychedelicmedicalnews.com/wp-content/uploads/2023/11/Veterans-Access-1024x512-500x300.jpg)
Canadian Senate Urges Immediate Action for Veterans’ Access to Psychedelic Therapies
1 2